Skip to main content
. 2015 Feb 14;49(3):800–808. doi: 10.1007/s12020-015-0548-3

Table 3.

Serum 25(OH)D in relation to demographic or lifestyle-related parameters in the blood donors

Serum 25(OH)D nmol/L
mean ± SD
Significance p value
Women versus men 65.6 ± 25.3 versus 61.0 ± 26.8 0.046
Women versus men (when sunbed users were excluded) 63.8 ± 22.9 versus 60.8 ± 27.0 0.20
Age ≤ 29 versus ≥51 years (first quartile versus forth quartile) 63.6 ± 30.2 versus 59.7 ± 21.8 0.213
BMI ≤ 22.4 versus ≥26.8 kg/m2 (first quartile versus forth quartile) 65.5 ± 26.3 versus 54.7 ± 22.2 <0.001
Smokers versus non-smokers 51.4 ± 26.2 versus 63.4 ± 26.2 0.031
Sunbed users versus non-users 82.2 ± 35.6 versus 62.0 ± 25.5 <0.001
Subjects on a sunny holiday during the previous month, yes versus no 86.9 ± 37.7 versus 61.1 ± 24.4 <0.001
Physically activea versus non-active 64.5 ± 26.7 versus 58.4 ± 24.7 0.015
Female study subjects using estrogensb versus non-users 84.0 ± 38.3 versus 63.3 ± 22.2 0.016
Vitamin D supplement users versus non-users (during the whole year) 64.7 ± 19.5 versus 62.7 ± 26.9 0.49
Vitamin D supplement users versus non-users (winter months only) 59.0 ± 21.0 versus 49.2 ± 19.4 0.01
Medication (other than vitamin D), users versus non-users 70.3 ± 34.2 versus 61.9 ± 24.9 0.065
Users of a vegetarian diet versus non-users 59.7 ± 23.1 versus 63.0 ± 26.4 0.53
Complementary and alternative medicine users versus non-users 63.3 ± 21.8 versus 62.8 ± 27.0 0.87

25(OH)D 25-hydroxy vitamin D, BMI body mass index

aPhysically active defined as performing physical exercise regularly at least once a week

bestrogens were taken as contraceptives or hormone replacement therapy

HHS Vulnerability Disclosure